SCHEMBL8028208

SCHEMBL8028208

O=C(CCl)Nc1cccc2c(O)cccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.59
HTT P42858 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
LMNA P02545 2/20 0.59
GAA P10253 2/20 0.55
TRPV1 Q8NER1 3/20 0.54
EP300 Q09472 1/20 0.49
POLB P06746 1/20 0.49
CDC25B P30305 3/20 0.47
CHEK1 O14757 1/20 0.47
DAPK3 O43293 1/20 0.47
PRKD3 O94806 1/20 0.47
MAP4K4 O95819 1/20 0.47
NTRK1 P04629 1/20 0.47
RET P07949 1/20 0.47
MET P08581 1/20 0.47
PIM1 P11309 1/20 0.47
FGFR1 P11362 1/20 0.47
PDGFRA P16234 1/20 0.47
LTK P29376 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2680971 0.90 EP300 (0.60) ALDH1A1HTTSMN1; SMN2LMNAEP300
SCHEMBL8030148 0.84 ALDH1A1 (0.56) ALDH1A1GAATRPV1EP300POLB
SCHEMBL7933998 0.83 ALDH1A1 (0.55) ALDH1A1GAATRPV1EP300POLB
SCHEMBL8016606 0.83 ALDH1A1 (0.55) ALDH1A1GAATRPV1EP300POLB
SCHEMBL4604147 0.82 ALDH1A1 (0.57) ALDH1A1HTTSMN1; SMN2LMNAGAA
SCHEMBL29728210 0.81 MAPT (0.68) ALDH1A1HTTSMN1; SMN2LMNAGAA
SCHEMBL4867099 0.81 MAPT (0.68) ALDH1A1HTTSMN1; SMN2LMNAGAA
SCHEMBL8032577 0.79 TSHR (0.58) ALDH1A1HTTGAATRPV1EP300
SCHEMBL27404464 0.79 ALDH1A1 (0.51) ALDH1A1GAATRPV1EP300POLB
SCHEMBL10957416 0.79 ALDH1A1 (0.51) ALDH1A1HTTSMN1; SMN2LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0603954-B1 Immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer JOHNSON & JOHNSON CLIN DIAG (US) 2000-03-08 EP disclosed
EP-0603953-B1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods JOHNSON & JOHNSON CLIN DIAG (US) 1999-02-17 EP disclosed
US-5736335-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1998-04-07 US disclosed
US-5641635-A Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase-labeled reagents EASTMAN KODAK COMPANY (US) 1997-06-24 US disclosed
US-5372932-A Peroxidase-labeled immunoreactant; stabiliztion with a 4-hydroxy or 4-alkoxyarylacetamide EASTMAN KODAK COMPANY (US) 1994-12-13 US disclosed
EP-0603953-A1 Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed
EP-0603954-A2 Analytical element and immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer Johnson & Johnson Clinical Diagnostics, Inc. (US) 1994-06-29 EP disclosed